Regeneron seeks to revamp the controversial relationships between pharma and patient charities The company is hoping to widen patient access to its eye drugs without also benefiting rivals

https://www.statnews.com/pharmalot/2025/06/24/pharma-biotech-regeneron-eyes-patients-charities-foundation-macular-genentech-retinal-roche-amgen-biosimilar/